Evidence map›Paper›PMID 38226510›Full record

ArticleJournal of the American Heart Association2024

Design and Feasibility Analysis of a Smartphone-Based Digital Cognitive Assessment Study in the Framingham Heart Study.

Preeti Sunderaraman, Ileana De Anda-Duran, Cody Karjadi, Julia Peterson, Huitong Ding, Sherral A Devine, Ludy C Shih, Zachary Popp, Spencer Low, Phillip H Hwang and 6 more

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Preeti SunderaramanDepartment of Neurology Boston University Chobanian & Avedisian School of Medicine School of Medicine Boston MA USA.ORCID 0000-0001-6011-8412
Ileana De Anda-DuranDepartment of Epidemiology Tulane University School of Public Health & Tropical Medicine New Orleans LA USA.ORCID 0000-0003-3629-9465
Cody KarjadiFramingham Heart Study Boston University Chobanian & Avedisian School of Medicine School of Medicine Boston MA USA.ORCID 0000-0001-9199-8723
Julia PetersonFramingham Heart Study Boston University Chobanian & Avedisian School of Medicine School of Medicine Boston MA USA.
Huitong DingFramingham Heart Study Boston University Chobanian & Avedisian School of Medicine School of Medicine Boston MA USA.
Sherral A DevineFramingham Heart Study Boston University Chobanian & Avedisian School of Medicine School of Medicine Boston MA USA.ORCID 0000-0002-5063-6651
Ludy C ShihDepartment of Neurology Boston University Chobanian & Avedisian School of Medicine School of Medicine Boston MA USA.
Zachary PoppBoston University Alzheimer's Disease Research Center Boston University Chobanian & Avedisian School of Medicine Boston MA USA.ORCID 0009-0001-7935-5300
Spencer LowBoston University Alzheimer's Disease Research Center Boston University Chobanian & Avedisian School of Medicine Boston MA USA.ORCID 0000-0003-1841-6701
Phillip H HwangDepartment of Epidemiology Boston University School of Public Health Boston MA USA.ORCID 0000-0001-6780-6808
Kriti GoyalDepartment of Neurology Boston University Chobanian & Avedisian School of Medicine School of Medicine Boston MA USA.
Lindsay HathawayFramingham Heart Study Boston University Chobanian & Avedisian School of Medicine School of Medicine Boston MA USA.
Jose MonteverdeFramingham Heart Study Boston University Chobanian & Avedisian School of Medicine School of Medicine Boston MA USA.
Honghuang LinDepartment of Medicine University of Massachusetts Chan Medical School Worcester MA USA.ORCID 0000-0003-3043-3942
Vijaya B KolachalamaBoston University Alzheimer's Disease Research Center Boston University Chobanian & Avedisian School of Medicine Boston MA USA.ORCID 0000-0002-5312-8644
Rhoda AuDepartment of Neurology Boston University Chobanian & Avedisian School of Medicine School of Medicine Boston MA USA.ORCID 0000-0001-7742-4491

Funding

TBDU19AG068753 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Thor Stein · 2020 to 2026
$42.4M
Assessing Alzheimer disease risk and heterogeneity using multimodal machine learning approachesU01AG068221 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DESTEFANO, ANITA L, LIN, HONGHUANG · 2021 to 2024
$2.5M
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study: Black & AA Recruitment SupplementRF1AG072654 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, GOLDSTEIN, LEE E. · 2021 to 2023
$2.4M
Mechanisms of drug-coated balloon therapyR01HL159620 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOLACHALAMA, VIJAYA B. · 2021 to 2024
$2.1M
Cognitive heterogeneity in those with high Alzheimer's Disease RiskR01AG062109 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Rhoda Au, Vijaya B. Kolachalama · 2025 to 2026
$1.6M
Modernizing the Assessment of Financial Decision Making: Development and Evaluation of a Simulated Online Money Management Task in Older AdultsR00AG062783 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SUNDERARAMAN, PREETI · 2022 to 2024
$723k
PRISTINE: Pre-cancer histology identification of Endobronchial biopsies using deep learningR21CA253498 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BEANE, JENNIFER ELLEN, KOLACHALAMA, VIJAYA B. · 2020 to 2020
$424k
Smartphone image analysis for real time adequacy assessment during kidney biopsyR43DK134273 · NIDDK · NEPHROPATHOLOGY ASSOCIATES · PI KOLACHALAMA, VIJAYA B., SHARMA, SHREE GOPAL · 2022 to 2022
$252k
NCI NIH HHS R21 CA253498NHLBI NIH HHS R01 HL159620NIA NIH HHS R00 AG062783NIA NIH HHS R01 AG062109NIA NIH HHS RF1 AG072654NIA NIH HHS U01 AG068221NIA NIH HHS U19 AG068753NIDDK NIH HHS R43 DK134273
6 · The paper itself

Abstract

backgroundSmartphone-based digital technology is increasingly being recognized as a cost-effective, scalable, and noninvasive method of collecting longitudinal cognitive and behavioral data. Accordingly, a state-of-the-art 3-year longitudinal project focused on collecting multimodal digital data for early detection of cognitive impairment was developed. METHODS AND

resultsA smartphone application collected 2 modalities of cognitive data, digital voice and screen-based behaviors, from the FHS (Framingham Heart Study) multigenerational Generation 2 (Gen 2) and Generation 3 (Gen 3) cohorts. To understand the feasibility of conducting a smartphone-based study, participants completed a series of questions about their smartphone and app use, as well as sensory and environmental factors that they encountered while completing the tasks on the app. Baseline data collected to date were from 537 participants (mean age=66.6 years, SD=7.0; 58.47% female). Across the younger participants from the Gen 3 cohort (n=455; mean age=60.8 years, SD=8.2; 59.12% female) and older participants from the Gen 2 cohort (n=82; mean age=74.2 years, SD=5.8; 54.88% female), an average of 76% participants agreed or strongly agreed that they felt confident about using the app, 77% on average agreed or strongly agreed that they were able to use the app on their own, and 81% on average rated the app as easy to use.

conclusionsBased on participant ratings, the study findings are promising. At baseline, the majority of participants are able to complete the app-related tasks, follow the instructions, and encounter minimal barriers to completing the tasks independently. These data provide evidence that designing and collecting smartphone application data in an unsupervised, remote, and naturalistic setting in a large, community-based population is feasible.

Indexed as

Mobile ApplicationsSmartphoneAgedCognitionFeasibility StudiesFemaleHumansLongitudinal StudiesMaleMiddle AgedSurveys and QuestionnairesagingAlzheimer's diseasedigital healthfeasibilitymobile health

Identifiers

PMID38226510
PMCPMC10926817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.